Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care
98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
Review IDs Exercise ‘Dose’ That May Improve Cognition in Seniors
52+ hours of exercise over 6 months tied to improved cognition for seniors with, without impairment
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Insomnia Found to Be Common but Mild in Older Adults
Insomnia significantly associated only with depressive symptoms, restless leg syndrome
Gaps in Care Post Discharge for Mild Traumatic Brain Injury
Thirty-nine percent with positive finding on CT had not seen medical practitioner within three months
CDC: Outpatient Rehab Rates Suboptimal for Stroke Survivors
Based on data from four states, in 2015, 35.5 percent of adult stroke survivors used outpatient rehab
Early-Life Weight Associated With Cognitive Factors
Inverse association between early-life weight status and perceptual reasoning, working memory scores
Global Variation in Personal Health Care Access and Quality
Highest performance in Iceland, lowest in Central African Republic, with variation in rate of progress
Neurologists Identify New Type of Vertigo
Long-term prognosis favorable, with improvement of symptoms in more than half of patients
